CAPTEM (capecitabine and temozolomide) provided a high rate of disease control in patients with typical and atypical lung carcinoid tumors, according to researchers.

Pharmaceuticals announced three abstracts from its clinical development programs will be presented at the upcoming North American ...

Somatostatin analogs (SSAs) like octreotide LAR and lanreotide are essential in managing NETs. Standard practice involves ...

Effective coordination among multidisciplinary team and individualized management strategies has emerged as a cornerstone of optimal NET care.

In clinical practice, dose adjustment for SSAs is a common strategy used to manage patients with neuroendocrine tumors (NETs). The primary reason for escalating the dose is to achieve better symptom ...